BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Ä¢¹½ÊÓÆµ//NONSGML v1.0//EN NAME:PhD defence S. Saha METHOD:PUBLISH BEGIN:VEVENT DTSTART:20250519T094500 DTEND:20250519T111508 DTSTAMP:20250519T094500 UID:2025/phd-defence-s-saha@8F96275E-9F55-4B3F-A143-836282E12573 CREATED:20250502T080512 LOCATION:(1st floor) Auditorium, Main building De Boelelaan 1105 1081 HV Amsterdam SUMMARY:PhD defence S. Saha X-ALT-DESC;FMTTYPE=text/html:

Ä¢¹½ÊÓÆµ

Value co-creation in an emerging domain: The case of G-protein coupled receptor (GPCR)-targe ted cancer research

Sneha Saha investigated the dynamics of in dividuals, groups, and organizations involved in interactive and coll aborative processes within the field of GPCR-targeted cancer research .

In cancer research, value co-creation is essential for drivin g innovation across various organizational settings, such as universi ties, small businesses, and large pharmaceutical companies. In emergi ng fields like G protein-coupled receptor (GPCR) research in oncology , collaboration is required to transform early discoveries. This nece ssity is specifically tied to the novel starting point of GPCR resear ch. GPCR is crucial because of its key characteristics: it represents a new approach in cancer research.

The various perspectives on value co-creation in an emerging field are fostered through interdis ciplinary learning and collaboration in cancer research. Saha provide s real-world evidence of the impact of innovation management by linki ng fundamental research to an emerging domain, based on rigorous and reliable data. Furthermore, she demonstrates how resource orchestrati on is critical for scientific leadership in academia and for ambidext erity in high-tech SMEs. Her research offers a theory-driven, data-dr iven roadmap to understand the impact of ambidextrous value co-creati on in cancer research.

DESCRIPTION: Sneha Saha investigated the dynamics of individuals, grou ps, and organizations involved in interactive and collaborative proce sses within the field of GPCR-targeted cancer research. In cancer res earch, value co-creation is essential for driving innovation across v arious organizational settings, such as universities, small businesse s, and large pharmaceutical companies. In emerging fields like G prot ein-coupled receptor (GPCR) research in oncology, collaboration is re quired to transform early discoveries. This necessity is specifically tied to the novel starting point of GPCR research. GPCR is crucial b ecause of its key characteristics: it represents a new approach in ca ncer research. The various perspectives on value co-creation in an em erging field are fostered through interdisciplinary learning and coll aboration in cancer research. Saha provides real-world evidence of th e impact of innovation management by linking fundamental research to an emerging domain, based on rigorous and reliable data. Furthermore, she demonstrates how resource orchestration is critical for scientif ic leadership in academia and for ambidexterity in high-tech SMEs. He r research offers a theory-driven, data-driven roadmap to understand the impact of ambidextrous value co-creation in cancer research. Valu e co-creation in an emerging domain: The case of G-protein coupled re ceptor (GPCR)-targeted cancer research END:VEVENT END:VCALENDAR